Panel Supports Smith & Nephew’s Birmingham Hip Resurfacing System
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopaedic & Rehabilitation Devices Panel narrowly recommended approval for Smith & Nephew's Birmingham Hip Resurfacing system Sept. 8, provided that the firm conducts a postmarket study
You may also be interested in...
Corin’s Cormet 2000 Hip Resurfacing System Is “Approvable With Conditions”
Corin's Cormet 2000 hip resurfacing system requires a postmarket study to address long-term safety concerns, FDA's Orthopedic and Rehabilitation Devices Panel recommended Feb. 22
Corin’s Cormet 2000 Hip Resurfacing System Is “Approvable With Conditions”
Corin's Cormet 2000 hip resurfacing system requires a postmarket study to address long-term safety concerns, FDA's Orthopedic and Rehabilitation Devices Panel recommended Feb. 22
FDA Ortho Panel Will See Second Hip Resurfacing System In Cormet
Corin Group's Cormet will be the second hip resurfacing product to go before an FDA advisory committee when the Orthopaedic and Rehabilitation panel considers the device's PMA next month